1. Lectins Purified from Medicinal and Edible Mushrooms: Insights into Their Antiviral Activity against Pathogenic Viruses. El-Maradny, Y.A., E.M. El-Fakharany, M.M. Abu-Serie, M.H. Hashish, and H.S. Selim. International Journal of Biological Macromolecules, 2021. 179: p. 239-258. PMID[33676978].
[PubMed]. HBV_06_2021.
2. Epigenetic Reprogramming Promotes the Antiviral Action of Ifnα in HBV-infected Cells. Gailhouste, L., M. Sudoh, X.Y. Qin, K. Watashi, T. Wakita, T. Ochiya, T. Matsuura, S. Kojima, and Y. Furutani. Cell Death Discovery, 2021. 7(1): 130. PMID[34078875]. PMCID[PMC8170866].
[PubMed]. HBV_06_2021.
3. Antiviral Activity of Methyl helicterate Isolated from Helicteres angustifolia (Sterculiaceae) against Hepatitis B Virus (Vol 100, Pg 373, 2013). Huang, Q.F., R.B. Huang, L. Wei, Y.X. Chen, S.J. Lv, C.H. Liang, X.R. Zhang, F.J. Yin, H.T. Li, L. Zhuo, and X. Lin. Antiviral Research, 2021. 186: 105017. PMID[33485675].
[PubMed]. HBV_06_2021.
4. A Novel Piperazine Derivative That Targets Hepatitis B Surface Antigen Effectively Inhibits Tenofovir Resistant Hepatitis B Virus. Kiruthika, S., R. Bhat, R. Dash, A.S. Rathore, P. Vivekanandan, and B. Jayaram. Scientific Reports, 2021. 11(1): 11723. PMID[34083665]. PMCID[PMC8175705].
[PubMed]. HBV_06_2021.
5. Repurposing of Antazoline hydrochloride as an Inhibitor of Hepatitis B Virus DNA Secretion. Li, J., Y. Hu, Y. Yuan, Y. Zhao, Q. Han, C. Liu, X. Hu, Y. Zhou, Y. Wang, Y. Guo, C. Wu, X. Chen, and R. Pei. Virologica Sinica, 2021. 36(3): p. 501-509. PMID[33165771].
[PubMed]. HBV_06_2021.
6. Antiviral Activity Exerted by Natural Products against Human Viruses. Musarra-Pizzo, M., R. Pennisi, I. Ben-Amor, G. Mandalari, and M.T. Sciortino. Viruses, 2021. 13(5): 828. PMID[34064347]. PMCID[PMC8147851].
[PubMed]. HBV_06_2021.
Patent Citations
7. Pyrrole-3-carboxamides as Hepatitis B Capsid Assembly Modulators and Their Preparation. Burns, C.J., G. Coburn, B. Liu, J. Yao, C. Benetatos, S.A. Boyd, S.M. Condon, and T. Haimowitz. Patent. 2021. 2020-US63936 2021119081: 150pp.
[Patent]. HBV_06_2021.
8. Substituted Bicyclic and Tricyclic Ureas and Amides, Analogues Thereof, and Methods Using Same. Cole, A.G., B.D. Dorsey, Y. Fan, S.G. Kultgen, and E.F. Mesaros. Patent. 2021. 2020-US65888 2021127356: 439pp.
[Patent]. HBV_06_2021.
9. Heteroaryldihydropyrimidine Derivatives and Methods of Treating Hepatitis B Infections. Deng, G., Z. Cheng, Z. Liu, C. Liang, J. Wu, L. Kong, X. Deng, Y. Jiang, and Y. Xu. Patent. 2021. 2020-CN137480 2021121363: 126pp.
[Patent]. HBV_06_2021.